Use of psychotropic medication among psychiatric out-patients with personality disorder

Psychiatrist

Volumn 34, Issue 3, 2010, Pages 83-86

  Baker Glenn, Elena ^a   Steels, Mark ^a   Evans, Chris ^b  

^a NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DOSULEPIN; MIRTAZAPINE; NITRAZEPAM; PSYCHOTROPIC AGENT; TRAZODONE; VENLAFAXINE; ZOPICLONE;

ADULT; AGED; BIPOLAR DISORDER; COST EFFECTIVENESS ANALYSIS; DELUSIONAL DISORDER; DRUG COST; EMOTIONALLY UNSTABLE PERSONALITY DISORDER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PERSONALITY DISORDER; POLYPHARMACY; PREVALENCE; REVIEW; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 77951122693     PISSN: 17583209     EISSN: 17583217     Source Type: Journal    
DOI: 10.1192/pb.bp.108.021758     Document Type: Review

References (16)

1. Lewis G, Appleby L. Personality disorder: the patients psychiatrists dislike. Br J Psychiatry 1988; 153: 44-49
2. Coid J,Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry 2006; 188: 423-431
3. National Institute for Mental Health for England. Personality Disorder: No Longer a Diagnosis of Exclusion. Policy Implementation Guidance for the Development of Services for People with Personality Disorder. NIMH(E), 2003.
4. Binks CA, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C. Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews, issue 1. Wiley, 2006.
5. Zanarini MC. Update on pharmacotherapy of borderline personality disorder. Curr Psychiatry Rep 2004; 6: 66-70. (Pubitemid 38899254)
6. Makela EH, Moeller KE, Fullen JE, Gunel E. Medication utilization patterns and methods of suicidality in borderline personality disorder. Ann Pharmacother 2006; 40: 49-52. (Pubitemid 43221474)
7. Sansone RA, Rytwinki D, Gaither GA. Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic. Compr Psychiatry 2003; 44: 454-458
8. Tyrer P, Bateman AW. Drug treatment for personality disorders. Adv Psychiatr Treat 2004; 10: 389-398
9. Davids E, Bunk C, Specka M, Gastpar M. Patterns of psychotropic drug use in personality disorder with emotional instability in a German University Hospital (abstract). Krankenhauspsychiatrie 2005; 16: 102-106 (Pubitemid 41419151)
10. Nissen T. Drug therapy of patients with emotionally unstable personality (abstract). Tidsskr Nor Laegeforen 2000; 120: 2135-2141
11. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-10). WHO, 1992.
12. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary, March issue. BMJ Books & Pharmaceutical Press, 2006.
13. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing (http://www.Rproject.org).
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
15. Tyrer P, Kendall T, Bateman A, Bayliss L, Bouras N, Burbeck R, et al. Draft NICE Guidelines for Consultation. Borderline Personality Disorder: Treatment and Management. NICE, 2008 (http://www.nice.org.uk/nicemedia/pdf/ BorderlinePersonalityDisorderFullGuidelineForConsultation.pdf).
16. Oldham JM, Bender DS, Skodol AE, Dyck IR, Sanislow CA, Yen S, et al. Testing an APA Practice Guideline: symptom-targeted medication utilization for patients with borderline personality disorder. Focus 2005; 3: 484-488 (Pubitemid 38669723)